ARROWHEAD PHARMACEUTICALS, INC. - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT PUBLIC REGISTERED ACCOUNTING FIRM

Attached files

file	filename
10-K - FORM 10-K - ARROWHEAD PHARMACEUTICALS, INC.	d10k.htm
EX-21.1 - LIST OF SUBSIDIARIES - ARROWHEAD PHARMACEUTICALS, INC.	dex211.htm
EX-32.1 - CERTIFICATION BY CHIEF EXECUTIVE OFFICER - ARROWHEAD PHARMACEUTICALS, INC.	dex321.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - ARROWHEAD PHARMACEUTICALS, INC.	dex312.htm
EX-32.2 - CERTIFICATION BY CHIEF FINANCIAL OFFICER - ARROWHEAD PHARMACEUTICALS, INC.	dex322.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - ARROWHEAD PHARMACEUTICALS, INC.	dex311.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in this Annual Report on Form 10-K of Arrowhead Research Corporation for the year ended September 30, 2010 of our report dated December 17, 2010 included in its Registration Statements on Forms S-3 (Nos. 333-148218, 333-144109, 333-137329, 333-132310, 333-124065, and 333-113065) and Forms S-8 (Nos. 333-170252, 333-136225, 333-124066, and 333-120072) relating to the consolidated financial statements of Arrowhead Research Corporation and Subsidiaries for the year ended September 30, 2010.

Rose, Snyder & Jacobs

A Corporation of Certified Public Accountants

Encino, California

December 17, 2010

Attached files

Stock widget

Investing forum

ARROWHEAD PHARMACEUTICALS, INC. Reports

Also read